A novel approach developed by a UB physician-scientist and colleagues to cure hepatitis C virus in people with opioid use disorder is being honored with a 2025 Top Ten Clinical Research Achievement Award.
A small percentage of patients taking GLP-1 medications have experienced vision problems, but a direct causal link with the drugs has not been established, according to a recent paper.
On June 6-8, faculty and students of the Jacobs School and the MSU College of Human Medicine will gather for Remembrance Conference 2025 at UB, the third time the schools are hosting this exchange.